top of page
Email written by the new president about Kenzo Nakajima's fraud

In the email below, we, Shin-ichi Nishikawa, Yoshiki Sasai, Hitoshi Niwa, who were the STAP cell group of Stem Cell Science and RIKEN, collaborated with the Advanced Medical Promotion Foundation to forge clinical data and invest. ANA Continental Hotel in Akasaka on December 24, pursuing the facts about [Stem Cell Science's paper fabrication fraud case] that tricked a house into fraudulently defrauding 300 to 700 million yen (later known to be 700 million yen) This is the email the day after the [Extraordinary Board of Directors Meeting] held in. At the meeting, Audit & Supervisory Board Member Nakahara and Kenzo Nakajima, who attended the telephone call, admitted fraud, so when consulting with a lawyer, they forged to dazzle the clinical trial of myoblast transplantation received from Audit & Supervisory Board Member Nakahara. It will be an email pointing out what was being done.

In the end, I went to consult with three lawyers with these materials, but everyone said, "This is a treatise forgery scam, so you should report it to the police. Otherwise, you will not be listed. It was decided to report to the police on December 28, so I told the auditors Nakahara, Kenzo Nakajima, Yoshiko Nakajima and others to that effect.

December 28th was the day when the eldest son of Mr. and Mrs. Ryan was discharged from the hospital, and Mr. and Mrs. Ryan were planning to celebrate the New Year in Kyoto, so it was decided by Kobe to talk to the police.

However, in reality, on the morning of December 28, the eldest son of Mr. and Mrs. Ryan was murdered at the hospitalized Defense University Hospital, where he was covered with a plastic bag twice on his head and fell from a brain-dead state to a plant-human state. The police report was put on hold because I couldn't go to Kyoto because I was involved in an attempted and unintentional incident.

Click here for more information on the case at National Defense Medical College Hospital

From: From:
Sent: Tuesday, December 25, 2007 10:32 AM
Subject: Celogos




I'm talking about myoblast transplantation. This also states that the goal is to start clinical trials in the second quarter of 2008, and it is the content to mislead shareholders.

There is no reality at all. On the other hand, Mr. Nakahara stated that he was a goal, so he said he didn't feel guilty. It's sad, is not it.

I will send you the clinical trial guide from Pharmaceuticals and Medical Devices Agency and the contents of the file I received from them as an attachment. If you would like to consult with a lawyer today, please refer to this as well.

In addition, hMADS also states that it is planning a clinical trial in the United States in 1-2Q of 2009, and I think it is necessary to confirm whether there are any documents related to it.


Rishi Gojo

bottom of page